Plasma exchange in multiple organ failure: Changing gears in sepsis and organ failure *

This publication has 22 references indexed in Scilit:

• Low-Dose Heparin for Severe Sepsis
  New England Journal of Medicine, 2002
• A phase II randomized, controlled trial of continuous hemofiltration in sepsis
  Critical Care Medicine, 2002
• High-Dose Antithrombin III in Severe Sepsis
  JAMA, 2001
• Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
  New England Journal of Medicine, 2001
• Coagulation Abnormalities in Acute Lung Injury and Sepsis
  American Journal of Respiratory Cell and Molecular Biology, 2000
• Hemofiltration for SIRS
  Critical Care Medicine, 1998
• Evidence-based analysis of the role of hemofiltration in sepsis and multiorgan dysfunction syndrome
  Current Opinion in Critical Care, 1997
• Inflammatory mediators in sepsis: rationale for extracorporeal therapies?
  American Journal of Kidney Diseases, 1996
• Plasma Levels of Cytokines in Primary Septic Shock in Humans: Correlation with Disease Severity
  The Journal of Infectious Diseases, 1995
• A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.
  Journal of Clinical Investigation, 1985